Arrowhead Pharmaceuticals Files Complaint for Declaratory Judgment Against Ionis Pharmaceuticals

Core Viewpoint - Arrowhead Pharmaceuticals, Inc. has filed a Complaint for Declaratory Judgment against Ionis Pharmaceuticals, Inc. to declare the invalidity of Ionis's U.S. Patent No. 9,593,333 and assert that Arrowhead's planned commercialization of investigational plozasiran does not infringe this patent [1] Company Summary - Arrowhead Pharmaceuticals is currently under FDA review for its investigational drug plozasiran [1] - The company intends to vigorously defend its position regarding the patent dispute with Ionis Pharmaceuticals [1] Industry Context - The legal action highlights ongoing patent disputes within the pharmaceutical industry, particularly concerning investigational drugs and their commercialization [1]